Standard adjuvant chemotherapy regimens for patients with moderate-to-high-risk early breast canc... more Standard adjuvant chemotherapy regimens for patients with moderate-to-high-risk early breast cancer typically contain a taxane, an anthracycline, and cyclophosphamide. We aimed to investigate whether integration of capecitabine into such a regimen enhances outcome.
Standard adjuvant chemotherapy regimens for patients with moderate-to-high-risk early breast canc... more Standard adjuvant chemotherapy regimens for patients with moderate-to-high-risk early breast cancer typically contain a taxane, an anthracycline, and cyclophosphamide. We aimed to investigate whether integration of capecitabine into such a regimen enhances outcome.
Uploads
Papers by Petri Bono